www.hivandhepatitis.com

The Liver Meeting (AASLD 2012)

November 9-13, 2012, Boston

4-Drug Oral Regimen Cures More than 90% of Chronic Hepatitis C Patients

Details
Category: HCV Treatment
Published on Tuesday, 23 October 2012 00:00
Written by Press Release
  • Print

An all-oral, interferon-free combination regimen containing 3 experimental direct-acting hepatitis C virus (HCV) drugs from Abbott plus ribavirin produced sustained virological response in 99% of previously untreated people with genotype 1 chronic hepatitis C and 93% of patients who experienced prior failure of interferon-based therapy, according to preliminary data from the ongoing Aviator study.alt

Read more:

Copyright © 2025 www.hivandhepatitis.com. All Rights Reserved. Designed by JoomlArt.com. Joomla! is Free Software released under the GNU General Public License.

Bread and Roses Web DesignWeb Design and Development by Bread and Roses Web Design